Global Congenital Heart Disease Market Size, Status and Forecast 2019-2025

Choose Licence

 

A congenital heart disease is a problem in the structure of the heart that is present at birth. The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number of dominating market players, growing demand for catheterization and application of cardiac biomarkers in congenital heart disease treatment are also considered as a major factor for driving the growth of the global congenital heart disease market during forecast period. In 2018, the global Congenital Heart Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Congenital Heart Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Congenital Heart Disease development in United States, Europe and China. The key players covered in this study Abbott Diagnostics Array BioPharma AstraZeneca Becton Dickinson BG Medicine Bio-Rad Boston Scientific Covance Critical Diagnostics Roche GSK Janssen Pharmaceuticals Medtronic Merck Mylan Market segment by Type, the product can be split into Medications Implantable heart devices Catheter procedures Open-heart surgery Heart transplant Market segment by Application, split into Hospitals and clinics Diagnostic centres Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Congenital Heart Disease status, future forecast, growth opportunity, key market and key players. To present the Congenital Heart Disease development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Congenital Heart Disease are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Congenital Heart Disease Market Size Growth Rate by Type (2014-2025) 1.4.2 Medications 1.4.3 Implantable heart devices 1.4.4 Catheter procedures 1.4.5 Open-heart surgery 1.4.6 Heart transplant 1.5 Market by Application 1.5.1 Global Congenital Heart Disease Market Share by Application (2014-2025) 1.5.2 Hospitals and clinics 1.5.3 Diagnostic centres 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Congenital Heart Disease Market Size 2.2 Congenital Heart Disease Growth Trends by Regions 2.2.1 Congenital Heart Disease Market Size by Regions (2014-2025) 2.2.2 Congenital Heart Disease Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Congenital Heart Disease Market Size by Manufacturers 3.1.1 Global Congenital Heart Disease Revenue by Manufacturers (2014-2019) 3.1.2 Global Congenital Heart Disease Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI) 3.2 Congenital Heart Disease Key Players Head office and Area Served 3.3 Key Players Congenital Heart Disease Product/Solution/Service 3.4 Date of Enter into Congenital Heart Disease Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Congenital Heart Disease Market Size by Type (2014-2019) 4.2 Global Congenital Heart Disease Market Size by Application (2014-2019) 5 United States 5.1 United States Congenital Heart Disease Market Size (2014-2019) 5.2 Congenital Heart Disease Key Players in United States 5.3 United States Congenital Heart Disease Market Size by Type 5.4 United States Congenital Heart Disease Market Size by Application 6 Europe 6.1 Europe Congenital Heart Disease Market Size (2014-2019) 6.2 Congenital Heart Disease Key Players in Europe 6.3 Europe Congenital Heart Disease Market Size by Type 6.4 Europe Congenital Heart Disease Market Size by Application 7 China 7.1 China Congenital Heart Disease Market Size (2014-2019) 7.2 Congenital Heart Disease Key Players in China 7.3 China Congenital Heart Disease Market Size by Type 7.4 China Congenital Heart Disease Market Size by Application 8 Japan 8.1 Japan Congenital Heart Disease Market Size (2014-2019) 8.2 Congenital Heart Disease Key Players in Japan 8.3 Japan Congenital Heart Disease Market Size by Type 8.4 Japan Congenital Heart Disease Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Congenital Heart Disease Market Size (2014-2019) 9.2 Congenital Heart Disease Key Players in Southeast Asia 9.3 Southeast Asia Congenital Heart Disease Market Size by Type 9.4 Southeast Asia Congenital Heart Disease Market Size by Application 10 India 10.1 India Congenital Heart Disease Market Size (2014-2019) 10.2 Congenital Heart Disease Key Players in India 10.3 India Congenital Heart Disease Market Size by Type 10.4 India Congenital Heart Disease Market Size by Application 11 Central & South America 11.1 Central & South America Congenital Heart Disease Market Size (2014-2019) 11.2 Congenital Heart Disease Key Players in Central & South America 11.3 Central & South America Congenital Heart Disease Market Size by Type 11.4 Central & South America Congenital Heart Disease Market Size by Application 12 International Players Profiles 12.1 Abbott Diagnostics 12.1.1 Abbott Diagnostics Company Details 12.1.2 Company Description and Business Overview 12.1.3 Congenital Heart Disease Introduction 12.1.4 Abbott Diagnostics Revenue in Congenital Heart Disease Business (2014-2019) 12.1.5 Abbott Diagnostics Recent Development 12.2 Array BioPharma 12.2.1 Array BioPharma Company Details 12.2.2 Company Description and Business Overview 12.2.3 Congenital Heart Disease Introduction 12.2.4 Array BioPharma Revenue in Congenital Heart Disease Business (2014-2019) 12.2.5 Array BioPharma Recent Development 12.3 AstraZeneca 12.3.1 AstraZeneca Company Details 12.3.2 Company Description and Business Overview 12.3.3 Congenital Heart Disease Introduction 12.3.4 AstraZeneca Revenue in Congenital Heart Disease Business (2014-2019) 12.3.5 AstraZeneca Recent Development 12.4 Becton Dickinson 12.4.1 Becton Dickinson Company Details 12.4.2 Company Description and Business Overview 12.4.3 Congenital Heart Disease Introduction 12.4.4 Becton Dickinson Revenue in Congenital Heart Disease Business (2014-2019) 12.4.5 Becton Dickinson Recent Development 12.5 BG Medicine 12.5.1 BG Medicine Company Details 12.5.2 Company Description and Business Overview 12.5.3 Congenital Heart Disease Introduction 12.5.4 BG Medicine Revenue in Congenital Heart Disease Business (2014-2019) 12.5.5 BG Medicine Recent Development 12.6 Bio-Rad 12.6.1 Bio-Rad Company Details 12.6.2 Company Description and Business Overview 12.6.3 Congenital Heart Disease Introduction 12.6.4 Bio-Rad Revenue in Congenital Heart Disease Business (2014-2019) 12.6.5 Bio-Rad Recent Development 12.7 Boston Scientific 12.7.1 Boston Scientific Company Details 12.7.2 Company Description and Business Overview 12.7.3 Congenital Heart Disease Introduction 12.7.4 Boston Scientific Revenue in Congenital Heart Disease Business (2014-2019) 12.7.5 Boston Scientific Recent Development 12.8 Covance 12.8.1 Covance Company Details 12.8.2 Company Description and Business Overview 12.8.3 Congenital Heart Disease Introduction 12.8.4 Covance Revenue in Congenital Heart Disease Business (2014-2019) 12.8.5 Covance Recent Development 12.9 Critical Diagnostics 12.9.1 Critical Diagnostics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Congenital Heart Disease Introduction 12.9.4 Critical Diagnostics Revenue in Congenital Heart Disease Business (2014-2019) 12.9.5 Critical Diagnostics Recent Development 12.10 Roche 12.10.1 Roche Company Details 12.10.2 Company Description and Business Overview 12.10.3 Congenital Heart Disease Introduction 12.10.4 Roche Revenue in Congenital Heart Disease Business (2014-2019) 12.10.5 Roche Recent Development 12.11 GSK 12.12 Janssen Pharmaceuticals 12.13 Medtronic 12.14 Merck 12.15 Mylan 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Congenital Heart Disease Key Market Segments Table Key Players Congenital Heart Disease Covered Table Global Congenital Heart Disease Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Congenital Heart Disease Market Size Market Share by Type 2014-2025 Figure Medications Figures Table Key Players of Medications Figure Implantable heart devices Figures Table Key Players of Implantable heart devices Figure Catheter procedures Figures Table Key Players of Catheter procedures Figure Open-heart surgery Figures Table Key Players of Open-heart surgery Figure Heart transplant Figures Table Key Players of Heart transplant Table Global Congenital Heart Disease Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals and clinics Case Studies Figure Diagnostic centres Case Studies Figure Congenital Heart Disease Report Years Considered Table Global Congenital Heart Disease Market Size 2014-2025 (Million US$) Figure Global Congenital Heart Disease Market Size and Growth Rate 2014-2025 (Million US$) Table Global Congenital Heart Disease Market Size by Regions 2014-2025 (Million US$) Table Global Congenital Heart Disease Market Size by Regions 2014-2019 (Million US$) Table Global Congenital Heart Disease Market Share by Regions 2014-2019 Figure Global Congenital Heart Disease Market Share by Regions 2014-2019 Figure Global Congenital Heart Disease Market Share by Regions 2019 Table Market Top Trends Table Global Congenital Heart Disease Revenue by Manufacturers (2014-2019) (Million US$) Table Global Congenital Heart Disease Market Share by Manufacturers (2014-2019) Figure Global Congenital Heart Disease Market Share by Manufacturers in 2018 Table Global Congenital Heart Disease Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Congenital Heart Disease Product/Solution/Service Table Date of Enter into Congenital Heart Disease Market Table Mergers & Acquisitions, Expansion Plans Table Global Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table Global Congenital Heart Disease Market Size Share by Type (2014-2019) Figure Global Congenital Heart Disease Market Size Market Share by Type (2014-2019) Table Global Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table Global Congenital Heart Disease Market Size Share by Application (2014-2019) Figure Global Congenital Heart Disease Market Size Market Share by Application (2014-2019) Figure Global Congenital Heart Disease Revenue Market Share by Application in 2018 Figure United States Congenital Heart Disease Market Size 2014-2019 (Million US$) Table United States Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table United States Key Players Congenital Heart Disease Market Share (2018-2019) Table United States Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table United States Congenital Heart Disease Market Share by Type (2014-2019) Table United States Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table United States Congenital Heart Disease Market Share by Application (2014-2019) Figure Europe Congenital Heart Disease Market Size 2014-2019 (Million US$) Table Europe Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table Europe Key Players Congenital Heart Disease Market Share (2018-2019) Table Europe Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table Europe Congenital Heart Disease Market Share by Type (2014-2019) Table Europe Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table Europe Congenital Heart Disease Market Share by Application (2014-2019) Figure China Congenital Heart Disease Market Size 2014-2019 (Million US$) Table China Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table China Key Players Congenital Heart Disease Market Share (2018-2019) Table China Congenital Heart Disease Market Size by Type (2014-20189) (Million US$) Table China Congenital Heart Disease Market Share by Type (2014-2019) Table China Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table China Congenital Heart Disease Market Share by Application (2014-2019) Figure Japan Congenital Heart Disease Market Size 2014-2019 (Million US$) Table Japan Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table Japan Key Players Congenital Heart Disease Market Share (2018-2019) Table Japan Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table Japan Congenital Heart Disease Market Share by Type (2014-2019) Table Japan Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table Japan Congenital Heart Disease Market Share by Application (2014-2019) Figure Southeast Asia Congenital Heart Disease Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Congenital Heart Disease Market Share (2018-2019) Table Southeast Asia Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Congenital Heart Disease Market Share by Type (2014-2019) Table Southeast Asia Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Congenital Heart Disease Market Share by Application (2014-2019) Figure India Congenital Heart Disease Market Size 2014-2019 (Million US$) Table India Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table India Key Players Congenital Heart Disease Market Share (2018-2019) Table India Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table India Congenital Heart Disease Market Share by Type (2014-2019) Table India Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table India Congenital Heart Disease Market Share by Application (2014-2019) Figure Central & South America Congenital Heart Disease Market Size 2014-2019 (Million US$) Table Central & South America Key Players Congenital Heart Disease Revenue (2018-2019) (Million US$) Table Central & South America Key Players Congenital Heart Disease Market Share (2018-2019) Table Central & South America Congenital Heart Disease Market Size by Type (2014-2019) (Million US$) Table Central & South America Congenital Heart Disease Market Share by Type (2014-2019) Table Central & South America Congenital Heart Disease Market Size by Application (2014-2019) (Million US$) Table Central & South America Congenital Heart Disease Market Share by Application (2014-2019) Table Abbott Diagnostics Company Details Table Abbott Diagnostics Revenue in Congenital Heart Disease Business (2014-2019) (Million US$) Figure Abbott Diagnostics Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Abbott Diagnostics Recent Development Table Array BioPharma Company Details Table Array BioPharma Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Array BioPharma Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Array BioPharma Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table AstraZeneca Recent Development Table Becton Dickinson Company Details Table Becton Dickinson Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Becton Dickinson Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Becton Dickinson Recent Development Table BG Medicine Company Details Table BG Medicine Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure BG Medicine Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table BG Medicine Recent Development Table Bio-Rad Company Details Table Bio-Rad Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Bio-Rad Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Bio-Rad Recent Development Table Boston Scientific Company Details Table Boston Scientific Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Boston Scientific Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Boston Scientific Recent Development Table Covance Company Details Table Covance Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Covance Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Covance Recent Development Table Critical Diagnostics Company Details Table Critical Diagnostics Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Critical Diagnostics Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Critical Diagnostics Recent Development Table Roche Company Details Table Roche Revenue in Congenital Heart Disease Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Congenital Heart Disease Business (2014-2019) Table Roche Recent Development Table GSK Company Details Table Janssen Pharmaceuticals Company Details Table Medtronic Company Details Table Merck Company Details Table Mylan Company Details Table Global Congenital Heart Disease Market Size by Regions (Million US$) 2019-2025 Figure Global Congenital Heart Disease Market Size Share by Regions (2019-2025) Figure Global Congenital Heart Disease Market Size Share by Regions in 2025 Figure United States Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Figure Europe Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Figure China Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Figure Japan Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Figure India Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Congenital Heart Disease Market Size Forecast (2019-2025)(Million USD) Table Global Congenital Heart Disease Market Size by Product (2019-2025) (Million US$) Figure Global Congenital Heart Disease Market Size by Product (2019-2025) Figure Global Congenital Heart Disease Market Size by Product in 2025 Table Global Congenital Heart Disease Market Size by Application (2019-2025) (Million US$) Figure Global Congenital Heart Disease Market Size by Application (2019-2025) Figure Global Congenital Heart Disease Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Medical Contract Manufacturing Market Size, Status and Forecast 2019-2025

In 2018, the global Medical Contract Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Medical Contract Manufacturing ...

Global Water-based Acrylic Enamel Paints Market Insights, Forecast to 2025

Global Water-based Acrylic Enamel Paints market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the f...

Global Acrylic Enamels Market Insights, Forecast to 2025

Global Acrylic Enamels market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to ...

Global Water Based Enamels Market Insights, Forecast to 2025

Global Water Based Enamels market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period...

Global Vitamin Tonics Market Insights, Forecast to 2025

The global Vitamin Tonics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vitamin...

New Pharmaceuticals and Healthcare Reports